Introgen Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics

INGN 6.865

+4.2%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: zeta1961 who wrote (672)	3/8/2007 2:04:14 PM
From: Jibacoa	Read Replies (3) of 802

According to them,INGN had 299,737 shares shorted at a volume weighted average short price of $3.990. $899,211.00 was shorted at this level and may begin short squeezing imminently. This represents a portion of the total short volume since January 2005. To see all the data, visit SqueezeTrigger.com . As of February 10th, the Total Short Interest was 4913099 shares. There are $19,603,265.01 worth of shares that have been shorted and have not yet covered. The stock is now trading at $4.10 It seems they are going to need some extra help from IF & Co.<g>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next